KR
36
-6
CNX
73
-3
JBHT
56
-3
MS
77
-2
DHI
44
-3
EXPD
43
-4
CI
45
-3
TGT
45
-4
HBI
58
3
PGR
59
-3
SWK
50
-5
MRO
50
4
CTSH
60
-3
DG
8
-2
HRB
59
2
SO
57
6
AMT
37
3
COF
62
3
ILMN
32
-9
CVX
43
-3
KR
36
-6
CNX
73
-3
JBHT
56
-3
MS
77
-2
DHI
44
-3
EXPD
43
-4
CI
45
-3
TGT
45
-4
HBI
58
3
PGR
59
-3
SWK
50
-5
MRO
50
4
CTSH
60
-3
DG
8
-2
HRB
59
2
SO
57
6
AMT
37
3
COF
62
3
ILMN
32
-9
CVX
43
-3
Financhill
Back

Jaguar Health Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
38

JAGX
Jaguar Health

Last Price:
0.95
Seasonality Move:
104.8%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
38
Jaguar Health (JAGX) is a Sell

Is Jaguar Health a Buy, Sell or Hold?

  • The current Jaguar Health [JAGX] share price is $0.96. The Score for JAGX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • JAGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JAGX Stock Price Chart

What is Jaguar Health's stock price today?

  • The Jaguar Health share price today is $0.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JAGX is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

JAGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 39.9 Sell
Chaikin Money Flow: -125456 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1 - 1.18) Sell
Bollinger Bands (100): (0.58 - 2.72) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

JAGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.99 Sell
20-day SMA: 1.06 Sell
50-day SMA: 1.14 Sell
200-day SMA: 4.35 Sell
8-day EMA: 1.01 Sell
20-day EMA: 1.05 Sell
50-day EMA: 1.27 Sell
200-day EMA: 24.92 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Jaguar Health Earnings Growth & JAGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $2.79 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Jaguar Health Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):